<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941028-2-00219</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=74 g=1 f=1 --> Index <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Acid-fast bacilli smears (see Smears, AFB) <!-- PJG 0012 frnewline --> Acquired immunodeficiency syndrome (see HIV infection) <!-- PJG 0012 frnewline --> Administrative controls <!-- PJG 0012 frnewline --> Aerosol therapy <!-- PJG 0012 frnewline --> Aerosolized pentamidine <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Booths for administration <!-- PJG 0012 frnewline --> Patient screening <!-- PJG 0012 frnewline --> Risk for nonsocomial transmission of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> M. tuberculosis <!-- PJG 0012 frnewline --> Tents for administration <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> AFB smears (see Smears, AFB) <!-- PJG 0012 frnewline --> AIDS (see HIV infection) <!-- PJG 0012 frnewline --> Air changes per hour (ACH) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> ASHRAE recommendations <!-- PJG 0012 frnewline --> Determining <!-- PJG 0012 frnewline --> Removal efficiencies <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Airflow <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Monitoring direction <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Ambulatory-care settings/areas <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Management of patients <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> American Conference of Governmental Industrial Hygienists, Inc. (ACGIH) <!-- PJG 0012 frnewline --> American Institute of Architects (AIA) <!-- PJG 0012 frnewline --> American Society of Heating, Refrigerating and Air-Conditioning Engineers, Inc. (ASHRAE) <!-- PJG 0012 frnewline --> Americans With Disabilities Act of 1990 <!-- PJG 0012 frnewline --> Anergy testing <!-- PJG 0012 frnewline --> Anesthesia considerations <!-- PJG 0012 frnewline --> Anterooms <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Negative pressure for <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Assignment of responsibility <!-- PJG 0012 frnewline --> Autopsy <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Risk for nonsocomial transmission of M. tuberculosis <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Autopsy rooms <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> HEPA filtration <!-- PJG 0012 frnewline --> Respiratory protection <!-- PJG 0012 frnewline --> UVGI <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Bacteriology <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Collecting specimens <!-- PJG 0012 frnewline --> Mixed mycobacterial infection <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> BCG (Bacille of Calmette and Gu&eacute;rin) vaccine <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Skin testing <!-- PJG 0012 frnewline --> Vaccination <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Bronchoscopy <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Ventilation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Chest radiography (see Diagnosis of TB) <!-- PJG 0012 frnewline --> Cluster (see PPD testing) <!-- PJG 0012 frnewline --> Cohorting <!-- PJG 0012 frnewline --> Community TB profile <!-- PJG 0012 frnewline --> Confidentiality <!-- PJG 0012 frnewline --> Contact investigation <!-- PJG 0012 frnewline --> Correctional facilities <!-- PJG 0012 frnewline --> Cough-inducing procedures <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Bronchoscopy <!-- PJG 0012 frnewline --> General guidelines <!-- PJG 0012 frnewline --> Home-health-care settings <!-- PJG 0012 frnewline -->  In ambulatory-care areas <!-- PJG 0012 frnewline --> Patient recovery from <!-- PJG 0012 frnewline --> Pentamidine, aerosolized <!-- PJG 0012 frnewline --> Respiratory protection <!-- PJG 0012 frnewline --> Risk for nonsocomial transmission of M. tuberculosis <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Sputum induction <!-- PJG 0012 frnewline --> Counseling <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Immunocompromised workers <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Culture methods <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Radiometric <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Decontamination of patient-care equipment <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Supplement 5_Decontamination, disinfecting, and sterilizing of patient-care equipment <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Dental care <!-- PJG 0012 frnewline --> Dental settings <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Infection-control precautions, TB <!-- PJG 0012 frnewline --> PPD screening program <!-- PJG 0012 frnewline --> Risk assessment <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Diagnosis of TB <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Anergy testing <!-- PJG 0012 frnewline --> Bacteriology (see Smears, AFB and Culture methods) <!-- PJG 0012 frnewline --> Before aerosol therapy <!-- PJG 0012 frnewline --> Bronchoscopy <!-- PJG 0012 frnewline --> Chest radiograph <!-- PJG 0012 frnewline --> Culturing <!-- PJG 0012 frnewline --> DNA probes <!-- PJG 0012 frnewline --> Fluorescent microscopy <!-- PJG 0012 frnewline --> High-pressure liquid chromatography <!-- PJG 0012 frnewline --> Hospitalized patients <!-- PJG 0012 frnewline --> Index of suspicion <!-- PJG 0012 frnewline --> Mantoux technique <!-- PJG 0012 frnewline --> Medical history <!-- PJG 0012 frnewline --> NAP test <!-- PJG 0012 frnewline --> Nucleic acid probes <!-- PJG 0012 frnewline --> PPD testing <!-- PJG 0012 frnewline --> Radiometric culture <!-- PJG 0012 frnewline --> Smears <!-- PJG 0012 frnewline --> Supplement 2_Diagnosis and treatment of latent TB infection and active TB <!-- PJG 0012 frnewline --> With anergy <!-- PJG 0012 frnewline --> With immunocompromising conditions <!-- PJG 0012 frnewline --> With simultaneous pulmonary infection <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Directly observed therapy (DOT) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Home-health-care settings <!-- PJG 0012 frnewline --> Public health department <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Discharge planning <!-- PJG 0012 frnewline --> Drug-resistant TB <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            